MedPage Today on MSN
Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial
NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single injection of the investigational drug zalunfiban at first medical contact, ...
The U.S. Food and Drug Administration said on Tuesday it appointed the agency's veteran oncology chief Richard Pazdur to oversee the department that reviews of new medicines, installing one of its few ...
One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
Although the pilot is starting small, county officials hope the center can be expanded on site and replicated across the ...
The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...
With no consensus among stakeholders, PJM Interconnection’s 10-member board now must craft a policy for surging data-center ...
The Orphan Drug Act has catalyzed innovation in rare disease treatments, but the law’s shortcomings — particularly around ...
9don MSN
Georgia attorney general warns parents about dangerous opioid-like drug being sold in gas stations
Georgia Attorney General Chris Carr is warning families about 7-OH, a potent opioid-like substance being sold in gas stations ...
In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...
With newly allocated funds, the Good News Rescue Mission aims to rehabilitate Shasta County's homeless. Here's how.
Q3 2025 Management View Matthew Duffy, Chief Business Officer & Co-CEO of Hope Therapeutics, opened the call stating, "Since the beginning of the third quarter, NRx has made transformative progress in ...
The Cincinnati Children’s Center has expanded its capacity to manufacture cellular products for rare diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results